Literature DB >> 6847175

In vitro activity of a group of broad-spectrum cephalosporins and other beta-lactam antibiotics against Chlamydia trachomatis.

M R Hammerschlag, A Gleyzer.   

Abstract

The activities of seven broad spectrum cephalosporins, four other beta-lactam antibiotics, and one monobactam against Chlamydia trachomatis were measured in a cell culture system. The minimal inhibitory concentration of four of the seven cephalosporins was greater than or equal to 128 micrograms/ml; those of the other three were from 16 to 32 micrograms/ml. Of the other agents, only mecillinam had activity against C. trachomatis comparable to that reported for ampicillin (minimal inhibitory concentration, less than or equal to 0.5 micrograms/ml).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847175      PMCID: PMC184677          DOI: 10.1128/AAC.23.3.493

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  In vitro activities of thirteen beta-lactam antibiotics against Chlamydia trachomatis.

Authors:  H L Muytjens; F W Heessen
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

2.  Activity of antimicrobials against Chlamydia trachomatis in vitro.

Authors:  G L Ridgway; J D Oriel
Journal:  J Antimicrob Chemother       Date:  1979-07       Impact factor: 5.790

3.  Lack of in vitro activity of cefoxitin, cefamandole, cefuroxime, and piperacillin against Chlamydia trachomatis.

Authors:  W R Bowie
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

4.  Eradication of Chlamydia trachomatis from the urethras of men with nongonococcal urethritis by treatment with amoxicillin.

Authors:  W R Bowie; E R Alexander; K K Holmes
Journal:  Sex Transm Dis       Date:  1981 Apr-Jun       Impact factor: 2.830

5.  Treatment of uncomplicated gonorrhea with cefotaxime.

Authors:  H H Handsfield; K K Holmes
Journal:  Sex Transm Dis       Date:  1981 Jul-Sep       Impact factor: 2.830

  5 in total
  13 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebae.

Authors:  M Maurin; A Bryskier; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

3.  In vitro effects of spectinomycin and ceftriaxone alone or in combination with other antibiotics against Chlamydia trachomatis.

Authors:  Shuxian Shang; Longqing Xia; Mingying Zhong; Jinping Zhang; Jianbin Zhao; Xiangdong Gong; David Mabey; Qianqiu Wang
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors:  H Talbot; B Romanowski
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

5.  In vitro activity of clavulanic acid, amoxicillin, and ticarcillin against Chlamydia trachomatis.

Authors:  W R Bowie
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

Review 6.  Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.

Authors:  I Phillips
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Affinities of beta-lactams for penicillin binding proteins of Chlamydia trachomatis and their antichlamydial activities.

Authors:  C Storey; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

8.  In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay.

Authors:  H Torres; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

Review 9.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

Review 10.  Beta-lactams in sexually transmitted diseases: rationale for selection and dosing regimens.

Authors:  D Kunimoto; R Brunham; A Ronald
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.